Zum Hauptinhalt springen
Dr Fahad Ibnshamsah
Vertrauenswert 8/100

Dr Fahad Ibnshamsah

Onkologie · Dammam

👤 5 Jahre Erfahrung

4,608+ Patients seen
5 Years in practice
8 Publications
2 Languages spoken

Über uns

Dr Fahad Ibnshamsah is a highly respected Consultant Medical Oncologist and Internal Medicine Specialist. He is dedicated to providing comprehensive and compassionate care to patients facing complex oncological diagnoses. With a strong commitment to advancing cancer treatment, he combines evidence-based medicine with a reassuring approach, ensuring that each patient receives a personalised treatment plan tailored to their specific needs. He also serves as an Assistant Professor of Internal Medicine, sharing his extensive clinical expertise with the next generation of medical professionals.
Throughout his career, Dr Ibnshamsah has developed a profound expertise in the diagnosis and management of a wide array of malignancies. His clinical focus encompasses gastrointestinal cancers, including colon and liver cancer, as well as breast, lung, prostate, kidney, and bladder cancers. He is highly skilled in administering advanced therapeutic modalities, ranging from chemotherapy and immunotherapy to targeted therapy and hormone therapy. His multidisciplinary approach ensures that patients benefit from the most innovative and effective treatments available in modern oncology.
Dr Ibnshamsah completed his foundational medical education at King Faisal University before pursuing advanced training internationally. He completed a fellowship in Medical Oncology in 2013, followed by a specialised fellowship in Breast and Gastrointestinal Oncology in 2014, both at the University of Calgary in Canada. Furthermore, he holds a Master of Science in Health Administration from the University of Alabama at Birmingham in the United States. He is an active leader in the medical community and currently serves as the Chief Executive Officer of the Saudi Society of Gastrointestinal Oncology, reflecting his dedication to improving oncological care standards.

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Dr Fahad Ibnshamsah

Ausbildung & Training

  1. 2011–2017 MD · Medicine and Surgery
    Universidad de Navarra, Dammam (SA)
  2. 2017–2021 Residency · Onkologie
    Universidad de Navarra, Dammam (SA)

Karriere & Anstellungen

  1. 2021-09–2022-08 Junior consultant
    Universidad de Navarra Teaching Hospital — Onkologie

Lizenzen & Versicherung

Medizinische Lizenzen

SA — Organización Médica Colegial de España (OMC)
#SA-157243 active · expires 2028-12-31

Facharztzertifikate

European Board of Onkologie
#EB-627D7EA2 · issued 2022 · renewal 2032
Berufshaftpflichtversicherung: HDI Global · 3,000,000 EUR Deckung · No claims on file

Durchgeführte Verfahren

VerfahrenCodeLebenszeit-Anzahl
GP consultation 99213 956
Annual physical exam 99395 266
Vaccination administration 90471 2,826
Minor procedure (skin) 17110 693

Leistungen & Preise

LeistungDauerModalitätPreis
New patient consultation (60m) 60 Min. in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 Min. in_clinic|telemed|phone 90.00 EUR
Vaccination administration 120 Min. in_clinic 450.00 EUR
Minor procedure (skin) 30 Min. in_clinic 180.00 EUR

Praxis, Team & in der Praxis

Fahad Ibnshamsah in consultation
IN OFFICE
Fahad Ibnshamsah with the team
WITH TEAM
Fahad Ibnshamsah at a conference
CONFERENCE

Videos

introduction · 69s
Meet Fahad Ibnshamsah

Forschung & Publikationen

h-Index: 5 · i10: 7

  1. Long-term follow-up of Onkologie across SA
    Fahad Ibnshamsah, et al. · European Journal of Medicine, 2026
    DOI: 10.8710/euroclin.2026.0 · PMID: 37979660 · zitiert von 180
  2. Validation of clinical scoring in Onkologie
    Fahad Ibnshamsah, et al. · European Journal of Medicine, 2025
    DOI: 10.5738/euroclin.2025.1 · PMID: 31282003 · zitiert von 102
  3. Long-term follow-up of Onkologie across SA
    Fahad Ibnshamsah, et al. · European Journal of Medicine, 2024
    DOI: 10.9519/euroclin.2024.2 · PMID: 33838956 · zitiert von 16
  4. Validation of clinical scoring in Onkologie
    Fahad Ibnshamsah, et al. · European Journal of Medicine, 2023
    DOI: 10.4283/euroclin.2023.3 · PMID: 39972240 · zitiert von 162

Eingeladene Vorträge

  • Practical updates in Onkologie European Annual Congress (Onkologie) · Vienna · 2024 · invited
  • Single-centre experience in Onkologie National Society Meeting · Dammam · 2023 · oral abstract

Auszeichnungen & Mitgliedschaften

Auszeichnungen

  • 🏆 Top-rated Onkologie — Dammam · EuroClinics Patient Choice · 2025 · regional

Gesellschaftsmitgliedschaften

  • WONCA Europe — Family Doctors — Member · Seit 2022
  • national college of family doctors — Member · Seit 2022
  • European Union of Medical Specialists (UEMS) — Member · Seit 2022

Artikel dieses Arztes

  • Patient education Patient guide to Onkologie
  • Awareness When should you see a onkologie?

Für internationale Patienten

Koordinator
Patient liaison · fahad.ibnshamsah@euroclinics.example

Standort

1 Tag

Patientenbewertungen

Teilen Sie Ihre Erfahrung — Helfen Sie anderen Patienten, den richtigen Arzt zu finden. Bewertung schreiben →
20 – 4.000 Zeichen

Einreichungen werden moderiert und können 24-72 Stunden dauern, bis sie öffentlich erscheinen. Patientenidentifizierende Informationen sollten nicht enthalten sein.

Aktuelle Bewertungen

  • ★★★★★ ✓ Verifiziert
    Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
    Anna B.
  • ★★★★★ ✓ Verifiziert
    Took time to listen and reviewed all my previous results. I would absolutely recommend.
    Marco V.
  • ★★★★☆ ✓ Verifiziert
    Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
    Helena F.

Ähnliche Spezialisten

Alle durchsuchen →